Zetta Genomics uses big data know-how to provide scalable genome storage and advanced analytics for genomic medicine in both research and healthcare settings.
Zetta is working to make its genome storage products, OpenCB and Zetta Enterprise, to become the de-facto platforms for genome data management for genomic medicine. This will allow Zetta to own a key part of the new $bn genomic data management sector within the $100bn healthcare information systems market.
As executive chairman, Jim led Zetta’s board of directors but also served as part of the management team, laying the foundations to make Zetta an enterprise SaaS company and securing a significant seed round investment with major UK and European VCs.